Manchester Financial Inc Bristol Myers Squibb CO Transaction History

Manchester Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $31,388 - $34,181	-507 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $11,868 - $13,347	200 Added 65.15%	507 $32,000
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $8,120 - $11,800	-175 Reduced 36.31%	307 $17,000
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $23,719 - $30,939	482 New	482 $31,000
Q3 2019 Oct 09, 2019	SELL	$42.77 - $50.71 $17,193 - $20,385	-402 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$44.62 - $49.34 $17,937 - $19,834	402 New	402 $18,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.